Evidence map›Paper›PMID 35031132›Full record

ReviewTrends in biotechnology2022

Optogenetic approaches in biotechnology and biomaterials.

Vasily V Reshetnikov, Sviatlana V Smolskaya, Sofia G Feoktistova, Vladislav V Verkhusha

Abstract readReview
In one paragraph

Review in Trends in biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Optogenetics in oral and craniofacial research.Journal of Zhejiang University. Science. B · 2024
    Review
  9. Photocobilins integrate BNature communications · 2024
    Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vasily V ReshetnikovScience Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia; Department of Molecular Genetics, Institute of Cytology and Genetics, Novosibirsk 630009, Russia.
Sviatlana V SmolskayaScience Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia.
Sofia G FeoktistovaScience Center for Genetics and Life Sciences, Sirius University of Science and Technology, Sochi 354340, Russia.
Vladislav V VerkhushaDepartment of Genetics, and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA; Medicum, Faculty of Medicine, University of Helsinki, Helsinki 00290, Finland. Electronic address: vladislav.verkhusha@einsteinmed.edu.

Funding

Near-Infrared Fluorescent Proteins, Biosensors and Optogenetic ToolsR35GM122567 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vladislav Verkhusha · 2017 to 2026
$4.3M
NIGMS NIH HHS R35 GM122567
6 · The paper itself

Abstract

Advances in genetic engineering, combined with the development of optical technologies, have allowed optogenetics to broaden its area of possible applications in recent years. However, the application of optogenetic tools in industry, including biotechnology and the production of biomaterials, is still limited, because each practical task requires the engineering of a specific optogenetic system. In this review, we discuss recent advances in the use of optogenetic tools in the production of biofuels and valuable chemicals, the synthesis of biomedical and polymer materials, and plant agrobiology. We also offer a comprehensive analysis of the properties and industrial applicability of light-controlled and other smart biomaterials. These data allow us to outline the prospects for the future use of optogenetics in bioindustry.

Indexed as

Biocompatible MaterialsOptogeneticsBiofuelsBiotechnologyGenetic EngineeringBiocompatible MaterialsBiofuelsbiofuelbiomasslight-controlphotoreceptorplant agrobiologysmart material

Identifiers

PMID35031132
PMCPMC9187586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.